You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 8, August 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of the Hypothalamic Hypophyseal Adrenal Axis in Patients Receiving Long-term Hemodialysis

German Ramirez, MD; Celso Gomez-Sanchez, MD; Wayne A. Meikle, MD; William Jubiz, MD

Arch Intern Med. 1982;142(8):1448-1452.


Abstract

Several alterations are present in the hypothalamic hypophyseal regulation of many hormones in patients with chronic renal failure. Evaluation of the hypothalamic hypophyseal adrenal axis in these groups of patients demonstrated normal levels of plasma cortisol. Dexamethasone suppression is abnormal after administration of 1 mg of oral dexamethasone, but normal after 3 mg. Dexamethasone blood levels were lower than the control after administration of 1 mg of oral dexamethasone. A dexamethasone metabolic clearance showed a similar half-life between the patients and controls. Oral absorption study showed poor absorption of the drug. Therefore, there is a problem of gastrointestinal absorption producing the abnormal dexamethasone suppression test in patients with renal failure. Results of metyrapone tests were normal. Corticotropin stimulation tests elicited a normal response. Insulin-induced hypoglycemia does not produce an increment in plasma cortisol or adrenocorticotropic hormone levels.

(Arch Intern Med 1982;142:1448-1452)



Author Affiliations

From the Divisions of Nephrology (Dr Ramirez) and Endocrinology (Dr Gomez-Sanchez), Department of Internal Medicine, University of South Florida, Tampa; the Division of Metabolism, University of Utah, Salt Lake City (Drs Meikle and Jubiz); and the Division of Nephrology, the Veterans Administration Hospital, Tampa, Fla (Dr Ramirez).


Footnotes

Accepted for publication April 20, 1982.

Reprint requests to Nephrology Section, James A. Haley Veterans Hospital, 13000 N 30th St, Tampa, FL 33612 (Dr Ramirez).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Nieman et al.
J. Clin. Endocrinol. Metab. 2008;93:1526-1540.
ABSTRACT | FULL TEXT  

A Physiologic Approach to Diagnosis of the Cushing Syndrome
Raff and Findling
ANN INTERN MED 2003;138:980-991.
FULL TEXT  

Renal Failure Obfuscates the Diagnosis of Cushing's Disease
Sharp et al.
JAMA 1986;256:2564-2565.
ABSTRACT  

Can the Pituitary Release Adrenocorticotropic Hormone During Stress?
Newmark
Arch Intern Med 1983;143:2248-2249.
ABSTRACT  

Normal Cortisol Response to Corticotropin in Patients With Secondary Adrenal Failure
Cunningham et al.
Arch Intern Med 1983;143:2276-2279.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.